NASDAQ: HCM
Hutchmed Ltd Stock Ownership - Who owns Hutchmed?

Insider buying vs selling

Have Hutchmed Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when HCM insiders and whales buy or sell their stock.

HCM Shareholders

What type of owners hold Hutchmed Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Schroder Investment Management Group0.30%2,579,349$40.39MInstitution
Allianz Asset Management Gmbh0.11%924,539$14.48MInstitution
State Street Corp0.04%328,792$5.15MInstitution
Aia Group Ltd0.04%315,439$4.94MInstitution
Goldman Sachs Group Inc0.03%289,135$4.53MInstitution
Mg PLC0.03%259,617$4.07MInstitution
Jane Street Group LLC0.02%175,961$2.76MInstitution
Amundi0.02%157,432$2.47MInstitution
Renaissance Technologies LLC0.01%129,000$2.02MInstitution
Catalyst Funds Management Pty Ltd0.01%109,845$1.72MInstitution

1 of 3

HCM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HCM0.70%0.00%
SUPN46.26%53.74%Net BuyingNet Buying
ALVO5.53%0.00%
INDV85.67%0.00%
PRGO63.16%36.84%Net BuyingNet Buying

Hutchmed Stock Ownership FAQ

Who owns Hutchmed?

Hutchmed (NASDAQ: HCM) is owned by 0.70% institutional shareholders, 0.00% Hutchmed insiders, and 99.30% retail investors. Schroder Investment Management Group is the largest individual Hutchmed shareholder, owning 2.58M shares representing 0.30% of the company. Schroder Investment Management Group's Hutchmed shares are currently valued at $40.62M.

If you're new to stock investing, here's how to buy Hutchmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.